SILVERARC CAPITAL MANAGEMENT, LLC 13F Holdings

CIK 0001816307 · BOSTON, MA

As of Sep 30, 2025, SILVERARC CAPITAL MANAGEMENT, LLC reported 82 positions worth $741.6M in its SEC Form 13F filing.

Top 25 holdings

SecurityTickerSectorSharesValue% of portfolio
ABIVAX SAABVXHealthcare539,704$45.8M6.18%
RHYTHM PHARMACEUTICALS INCRYTMHealthcare369,996$37.4M5.04%
AVIDITY BIOSCIENCES INCRNAHealthcare844,633$36.8M4.96%
NUVALENT INCNUVLHealthcare372,300$32.2M4.34%
UROGEN PHARMA LTDURGNHealthcare1,577,283$31.5M4.24%
AKERO THERAPEUTICS INCAKROHealthcare643,636$30.6M4.12%
INSMED INCINSMHealthcare206,648$29.8M4.01%
DIANTHUS THERAPEUTICS INCDNTHHealthcare674,966$26.6M3.58%
UNIQURE NVQUREHealthcare455,000$26.6M3.58%
CG ONCOLOGY INCCGONHealthcare638,346$25.7M3.47%
UNITED THERAPEUTICS CORP DEL——59,900$25.1M3.39%
ORIC PHARMACEUTICALS INCORICHealthcare1,948,808$23.4M3.15%
CIDARA THERAPEUTICS INCCDTXHealthcare220,902$21.2M2.85%
FRACTYL HEALTH INCGUTSHealthcare10,600,000 6.9M2.27%
KALVISTA PHARMACEUTICALS INCKALVHealthcare1,363,378 6.6M2.24%
KODIAK SCIENCES INCKODHealthcare1,000,000 6.4M2.21%
ULTRAGENYX PHARMACEUTICAL IN——528,200 5.9M2.14%
GOSSAMER BIO INCGOSSHealthcare4,779,082 2.6M1.69%
COGENT BIOSCIENCES INCCOGTHealthcare815,075 1.7M1.58%
CYTOKINETICS INCCYTKHealthcare211,000 1.6M1.56%
VAXCYTE INCPCVXHealthcare314,339 1.3M1.53%
BIOGEN INCBIIBHealthcare80,419 1.3M1.52%
ASCENDIS PHARMA AASNDHealthcare53,554 0.6M1.44%
COMPASS THERAPEUTICS INCCMPXHealthcare2,833,988$9.9M1.34%
AMYLYX PHARMACEUTICALS INCAMLXHealthcare700,000$9.5M1.28%